In vitro susceptibilities of malassezia species to a new triazole, albaconazole (ur-9825), and other antifungal compounds

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 7, 2003, Pages 2342-2344

  Garau, Margarita ^a   Pereiro Jr , Manolo ^b   Del Palacio, Amalia ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBACONAZOLE; ANTIFUNGAL AGENT; ECONAZOLE; FENTICONAZOLE; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VORICONAZOLE;

ARTICLE; COLORIMETRY; DRUG ACTIVITY; DRUG SCREENING; DRUG SENSITIVITY; MALASSEZIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MALASSEZIA; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; QUINAZOLINES; TRIAZOLES;

EID: 0038650939     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.7.2342-2344.2003     Document Type: Article

References (30)

1. Ahn, K. J., and H. R. Ashbee. 1996. Determination of minimum inhibitory concentrations of several azole antifungals for Malassezia furfur. Ann. Dermatol. 8:187-194.
2. Bartrolí, J., E. Turmo, M. Algueró, E. Boncompte, M. L. Vericat, L. Conte, J. Ramis, M. Merlos, J. García-Rafanell, and J. Forn. 1998. New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted 4 (3H)-quinazolinones. J. Med. Chem. 41:1869-1882.
3. Belkum, A., T. Boekhout, and R. Bosboom. 1994. Monitoring spread of Malassezia infections in a neonatal intensive care unit by PCR-mediated genetic typing. J. Clin. Microbiol. 32:2528-2532.
4. Capilla, J., M. Ortoneda, F. J. Pastor, and J. Guarro. 2001. In vitro antifungal activities of the new triazole UR-9825 against clinically important filamentous fungi. Antimicrob. Agents Chemother. 45:2635-2637.
5. Carrillo, A. J., and J. Guarro. 2001. In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob. Agents Chemother. 45:2151-2153.
6. Crespo Erchiga, V., A. Ojeda Martos, A. Vera Casano, A. Crespo Erchiga, and F. Sanchez Fajardo. 1999. Aislamiento e identificación de Malassezia spp. en pitiriasis versicolor, dermatitis seborreica y piel sana. Rev. Iberoam. Micol. 16:S16-S21.
7. Danker, W. M., and S. A. Spector. 1985. Malassezia furfur sepsis in neonates. J. Pediatr. 197:643-644.
8. Faergemann, J. 1984. In vitro and in vivo activities of ketoconazole and itraconazole against Pityrosporum orbiculare. Antimicrob. Agents Chemother. 26:773-774.
9. Faergemann, J., and M. Borgers. 1990. The effect of ketoconazole and itraconazole on the filamentous form of Pityrosponim ovale. Acta Dermat.-Venereol. 70:172-176.
10. Fernandez-Torres, B., A. J. Carrillo, E. Martín, A. del Palacio, M. K. Moore, A. Valverde, M. Serrano, and J. Guarro. 2001. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob. Agents Chemother. 45:2524-2528.
11. Guillot, J., E. Guého, M. Lesourd, G. Midgley, G. Chevrier, and B. Dupont. 1996. Identification of Malassezia species: a practical approach. J. Med. Mycol. 6:103-110.
12. Gupta, A. K., Y. Kohli, and R. C. Summerbell. 2000. Molecular differentiation of seven Malassezia species. J. Clin. Microbiol. 38:1869-1875.
13. Gupta, A. K., Y. Kholi, A. Li., J. Faergemann, and R. C. Summerbell. 2000. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. J. Clin. Microbiol. 142:758-765.
14. Hammer, K. A., C. F. Carson, and T. V. Riley. 2000. In vitro activities of ketoconazole, econazole, miconazole, and Melaleuca alternifolia (tea tree) oil against Malassezia species. Antimicrob. Agents Chemother. 44:467-469.
15. Leeming, J. P., and F. H. Notman. 1987. Improved methods for isolation and enumeration of Malassezia furfur from human skin. J. Clin. Microbiol. 25:2017-2019.
16. Marcon, M. J., and D. A. Powell. 1992. Human infections due to Malassezia species. Clin. Microbiol. Rev. 5:101-119.
17. Marcon, M. J., D. E. Durrell, D. A. Powell, and W. J. Buesching. 1987. In vitro activity of systemic antifungal agents against Malassezia furfur. Antimicrob. Agents Chemother. 31:951-953.
18. Mayser, P., P. Haze, C. Papavassilis, M. Pickel, K. Gruender, and E. Guého. 1997. Differentiation of Malassezia species: selectivity of Cremophor EL, castor oil and ricinoleic acid for M. furfur. Br. J. Dermatol. 137:209-213.
19. Midgley, G. 1989. The diversity of Pityrosporum (Malassezia) yeasts in vivo and in vitro. Mycopathologia 106:143-153.
20. Nakamura, Y., R. Kano, T. Murai, S. Watanabe, and A. Hasegawa. 2000. Susceptibility testing of Malassezia species using the urea broth microdilution method. Antimicrob. Agents Chemother. 44:2185-2186.
21. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
22. Palacin, C., C. Tarragó, and J. A. Ortiz. 1998. In vitro activity of sertaconazole against Malassezia furfur and pachydermatis in different culture media. Methods Find. Exp. Clin. Pharmacol. 20:451-455.
23. Ramos, G., M. Cuenca-Estrella, A. Monzon, and J. L. Rodríguez-Tudela. 1999. In vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp. J. Antimicrob. Chemother. 44:283-286.
24. Richet, H. M., M. M. McNeil, M. C. Edwards, and W. R. Jarvis. 1989. Cluster of Malassezia furfur pulmonary infections in a neonatal intensive care unit. J. Clin. Microbiol. 27:1197-1200.
25. Schmidt, A., and B. Rühl-Hörster. 1996. In vitro susceptibility of Malassezia furfur against azole compounds. Mycoses 39:309-312.
26. Strippoli, V., A. Piacentini, F. D. D'Auria, and N. Simonetti. 1997. Antifungal activity of ketoconazole and other azoles against Malassezia furfur in vitro and in vivo. Infection 25:303-306.
27. Van Abbe, N. J. 1964. The investigation of dandruff. J. Soc. Cosmet. Chem. 15:609-630.
28. Van Cutsem, J., F. Van Gerven, J. Fransen, P. Schrooten, and P. A. J. Janssen. 1989. The in vitro antifungal activity of ketoconazole, zinc pyrithione, and selenium sulfide against Pityrosporum and their efficacy as a shampoo in the treatment of experimental pityrosporosis in guinea pigs. J. Am. Acad. Dermatol. 22:993-998.
29. Van Gerven, F., and F. C. Odds. 1995. The anti-Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole, and sertaconazole. Mycoses 38:389-393.
30. Welbel, S. F., M. M. McNeil, A. Pramanik, R. Silberman, A. D. Orbele, G. Midgley, S. Crow, and W. R. Jarvis. 1994. Nosocomial Malassezia pachydermatis bloodstream infections in a neonatal intensive care unit. Pediatr. Infect. Dis. J. 13:104-108.